Skip to main content
Premium Trial:

Request an Annual Quote

NHGRI Planners Seek Comments on Next-Gen Sequencing

NEW YORK (GenomeWeb News) — The National Human Genome Research Institute is asking for feedback from the research community on how next-generation DNA sequencing technologies affect biomedical research and medicine.

The institute detailed its questions about next-gen sequencing in a new white paper, called "The Future of Genome Sequencing." It is the fourth in a series of papers aimed at generating a public dialogue about NHGRI's role in supporting genomics research over the coming years.

In the paper, which presents a number of questions about the future of sequencing, NHGRI said it is particularly interested in finding out if it is asking "the right questions" and if there are others it should be asking.

NHGRI posed a number of questions about the consequences of next-generation sequencing technologies on medicine and biomedical research, including:

• How will metagenomic sequencing, resequencing, and de novo genome sequencing be used?
• What community resources are needed that can be generated using next-gen technologies?
• What scale of sequencing will be required to address these questions?
• What impact will these technologies have on data analysis and informatics and what software and data storage needs will they create?
• Will sequencing efforts need to be organized differently to accommodate the new technologies?
• Should funding agencies anticipate the rapidly changing sequencing technologies?
• How will new technologies affect the current approach that is centered on a few very large production-oriented centers in terms of the generation of sequence data and the associated informatics requirements?
• Are there some projects that only large centers can accomplish, or is there some merit in de-centralizing the sequencing resources?

In addition, NHGRI has posed several questions related to the value of new sequencing technologies for basic research, clinical research, and healthcare delivery, and how data from this research can be used to improve human health.

The white paper can be found here.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.